Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|
Sponsor | - | - | 1 | |||||
Assets | ||||||||
Assets Current | ||||||||
Cash And Cash Equivalents At Carrying Value | 0 | - | - | |||||
Cash | 0 | 0 | 0 | |||||
Prepaid Expense Current | 0 | 0 | 0 | |||||
Assets Current | 0 | 0 | 1 | |||||
Assets Noncurrent | ||||||||
Assets Held In Trust Noncurrent | 509 | 505 | 500 | |||||
Assets Noncurrent | 509 | 505 | - | |||||
Assets | 510 | 505 | 501 | |||||
Liabilities And Stockhold… | ||||||||
Liabilities Current | ||||||||
Other Liabilities Current | - | 0 | 1 | |||||
Accounts Payable Current | 0 | 0 | 0 | |||||
Accrued Liabilities Current | 0 | 0 | 0 | |||||
Notes Payable Current | 0 | - | - | |||||
Liabilities Current | 1 | 0 | 1 | |||||
Liabilities Noncurrent | ||||||||
Liabilities Noncurrent | 18 | 18 | - | |||||
Liabilities | 18 | 18 | 18 | |||||
Temporary Equity Carrying Amount Attributable To P… | 509 | 505 | 500 | |||||
Stockholders Equity | ||||||||
Common Stock Value | 0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -18 | -18 | -17 | |||||
Stockholders Equity | -18 | -18 | -17 | |||||
Liabilities And Stockholders Equity | 510 | 505 | 501 | |||||
Over Allotment Option | - | 0 | - | |||||
Common Stock | - | 14 | - | |||||
Allowance For Doubtful Accounts Receivable Current | 1 | 1 | - | |||||
Temporary Equity Shares Outstanding | 50 | 50 | 50 | |||||
Temporary Equity Redemption Price Per Share | 10.19 | 10.1 | 10 | |||||
Preferred Stock Shares Authorized | 1 | 1 | 1 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 220 | 220 | 220 | |||||
Common Stock Shares Issued | 14 | 14 | 16 | |||||
Shares Outstanding | 14 | 14 | 16 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|
| 2026 | 0.50% | 0.60% | - | - | - | - |
| 2025 | - | - | - | 0.10% | 0.80% | 0.90% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Drugs Made In America Acquisition II Corp. (DMII) — SEC Financial Statements & Analysis
Drugs Made In America Acquisition II Corp. (DMII) is a blank checks company. Drugs Made In America Acquisition II Corp. trades on DMIIU: Nasdaq as: DMII: Nasdaq, DMIIR: Nasdaq. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Drugs Made In America Acquisition II Corp. reported a Debt-to-Equity ratio of -1.02x, a Price-to-Book (P/B) ratio of -27.98 (TTM), at a market cap of $498.50M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.02x
- P/B TTM
- -27.98
- Market Cap
- $498.50M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Drugs Made In America Acquisition II Corp. in?
Drugs Made In America Acquisition II Corp. (DMII) operates in the Blank Checks industry.
What is DMII's market cap?
Drugs Made In America Acquisition II Corp. (DMII) has a market capitalization of $498.50M as of 2026-03-31.
What exchange does DMII trade on?
Drugs Made In America Acquisition II Corp. (DMII) trades on the DMIIU: Nasdaq.